DNA Expert Witnesses in New York

This highly-qualified expert has 14 years of experience in the field of biopharmaceutical development, having earned her BS in biology from the University of North Carolina and her PhD in genetics from the University of California at San Francisco. Her work focuses on drug development with a particular focus on gene and cell therapies, including those with the following elements: AAV, Adenovirus, CRISPR, Zfn, Endonuclease, CAR-T, mRNA, LNP, Lentivirus, HSPC. She has worked in positions such as principal consultant for Halloran Consulting Group, the founder and CEO of Tremont Therapeutics, the senior director of Shire PLC, and the executive director of CRISPR Therapeutics. She is also involved in research in her field as an author of several scientific articles. This expert currently works as the principal at a drug development consulting company in Massachusetts.

This senior pathologist is Board Certified in neuropathology and anatomic pathology, and trained in forensic pathology. He earned his M.D. and a Ph.D. in Experimental Pathology from the University of Chicago. The expert spent the major part of his career in academia including positions as a professor of pathology and vice chairperson of the department of pharmacological and physiological sciences at the University of Chicago, as the chair of the department of pathology at Albert Einstein College of Medicine, and as an endowed professor of pathology and neurology at Emory University. he has coauthored over 140 publications and is a member of several relevant medical associations, including the American Association of Investigative Pathology, the American Association of Neuropathologists, and the International Academy of Pathology. Since 2010 this expert practiced forensic pathology in several major metropolitan offices. He has been qualified as an expert and testified in numerous criminal and civil trials. He currently works privately as an expert consultant in anatomic, neuropathology and forensic pathology.

This qualified expert earned his BS from the Massachusetts Institute of Technology and his MD from Stanford University School of Medicine. He completed his internship and residency in internal medicine at Mt. Sinai Hospital and his fellowships in rheumatology and clinical immunology at Yale University School of Medicine. In addition to being board certified in internal medicine and rheumatology, this expert has extensive experience in clinical work, academia, and the pharmacy industry. Early in his career, he served as an Internist and Chief of Internal Medicine at Westchester Community Health Plan and Chief of Rheumatology at VAMC-Syracuse. He was a Professor at UMDNJ-Robert Wood Johnson Medical School in the Department of Pediatrics, Medicine, and Molecular Genetics and Microbiology. This expert was also the Medical Director of Immunology at Bristol-Myers Squibb's Pharmaceutical Research Institute, Vice President of NovoNordisk's Medical-Science Inflammation Department, and Vice President of Immunology and Rheumatology at Parexel International. Currently, he is a Clinical Professor at a medical school in New Jersey and is President of a firm that provides consultation services in immunology and rheumatology focusing on molecules in development.